Agree completely with you Wendy. The company has made clear the timelines by which they intend to commence clinical trials. We can look forward to a TD2(U.S.)Phase 1 clinical trial and a CNS(Australia)Phase 2B clinical trial beginning sometime in 3Q15, which is within the next three months. An additional TD2(U.S.)Phase 1 clinical trial is also scheduled to begin sometime in 4Q15, but will have different endpoints than the other previously mentioned Phase 1. The first Phase 1 will examine quality of life for pancreatic cancer patients and the second Phase 1 will concentrate on the reduction/remission of malignant ascites for abdominal cancers. Day traders and shorts will play their game like they always do - this is of no consequence to me because I don't intend to sell for a very long time. Anyway, even when I do unload some of my shares at +1pps I fully intend to maintain over half of my position. Some good things are coming and I do think the initiation of clinical trials will be a catalyst to dollarland. In the meantime, all we have to do is sit back and relax - Mr. Waggoner and Dr.Crabtree have my fullest confidence, not to mention Dr. Salmons, Prof.Gunzburg, Dr.Brandtner, Dr.Lohr and Dr. Daniel Von Hoff. This is an exceptional, world class team which will soon prove its merit via clinical trials. Without question, the time to be in, and stay in, is now. When the first clinical trial is announced, all anyone on the sidelines is going to see is the (*)'s and elbows of everyone running trying to catch this thing.
News 
Market Data 
Discover 
